• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Increased cortical bone mineralization in imatinib treated patients with chronic myelogenous leukemia.

作者信息

Jönsson Sofia, Olsson Bob, Ohlsson Claes, Lorentzon Mattias, Mellström Dan, Wadenvik Hans

出版信息

Haematologica. 2008 Jul;93(7):1101-3. doi: 10.3324/haematol.12373. Epub 2008 May 27.

DOI:10.3324/haematol.12373
PMID:18508797
Abstract
摘要

相似文献

1
Increased cortical bone mineralization in imatinib treated patients with chronic myelogenous leukemia.伊马替尼治疗的慢性髓性白血病患者皮质骨矿化增加。
Haematologica. 2008 Jul;93(7):1101-3. doi: 10.3324/haematol.12373. Epub 2008 May 27.
2
Imatinib-induced cytogenetic remission in chronic eosinophilic leukaemia.伊马替尼诱导慢性嗜酸性粒细胞白血病的细胞遗传学缓解。
Intern Med J. 2006 Aug;36(8):537-8. doi: 10.1111/j.1445-5994.2006.01122.x.
3
Different kinetic patterns of BCR-ABL transcript levels in imatinib-treated chronic myeloid leukemia patients after achieving complete cytogenetic response.伊马替尼治疗的慢性髓性白血病患者在获得完全细胞遗传学缓解后BCR-ABL转录水平的不同动力学模式。
Int J Lab Hematol. 2008 Aug;30(4):317-23. doi: 10.1111/j.1751-553X.2007.00962.x.
4
Persistent neutropenia in chronic myelogenous leukemia in chronic phase treated with imatinib mesylate.甲磺酸伊马替尼治疗慢性期慢性粒细胞白血病时的持续性中性粒细胞减少症。
Am J Hematol. 2009 May;84(5):302-5. doi: 10.1002/ajh.21383.
5
Imatinib treatment of seropositive arthritis in a young woman with chronic myeloid leukemia.伊马替尼治疗一名患有慢性粒细胞白血病的年轻女性的血清阳性关节炎。
J Rheumatol. 2008 Aug;35(8):1682.
6
Achievement of complete molecular responses in late chronic phase chronic myeloid leukaemia patients treated with pulsed imatinib while in minimal residual disease.
Leuk Res. 2009 May;33(5):645-8. doi: 10.1016/j.leukres.2008.10.024. Epub 2008 Dec 4.
7
Persistence of molecular remission throughout pregnancy in CML after imatinib.伊马替尼治疗后慢性粒细胞白血病患者孕期分子缓解的持续情况。
Leuk Res. 2009 Jun;33(6):e6-7. doi: 10.1016/j.leukres.2008.09.012. Epub 2008 Oct 19.
8
Brain natriuretic peptide level as marker of cardiac function in imatinib--treated chronic myeloid leukemia patients: no evidence of cardiotoxicity of imatinib therapy.脑钠肽水平作为伊马替尼治疗慢性髓性白血病患者心功能的标志物：无伊马替尼治疗心脏毒性的证据
Am J Hematol. 2008 Jun;83(6):517-8. doi: 10.1002/ajh.21157.
9
Longstanding remission of adult onset Still's disease under imatinib therapy in a patient with chronic myelogenous leukemia.伊马替尼治疗慢性粒细胞白血病患者时成人斯蒂尔病获得长期缓解
J Rheumatol. 2009 Jun;36(6):1349-51. doi: 10.3899/jrheum.081159.
10
Successful imatinib mesylate therapy for acquired von Willebrand syndrome in chronic myelogenous leukemia.甲磺酸伊马替尼成功治疗慢性粒细胞白血病获得性血管性血友病综合征
Leuk Res. 2009 Dec;33(12):1723-4. doi: 10.1016/j.leukres.2009.05.011. Epub 2009 Jul 5.

引用本文的文献

1
Effect of the tyrosine kinase inhibitors on the growth in children with Philadelphia chromosome-positive acute lymphoblastic leukemia: a case-control study.酪氨酸激酶抑制剂对费城染色体阳性儿童急性淋巴细胞白血病生长的影响：一项病例对照研究。
Lancet Reg Health West Pac. 2023 Jun 10;38:100818. doi: 10.1016/j.lanwpc.2023.100818. eCollection 2023 Sep.
2
Bone Metabolism Effects of Medical Therapy in Advanced Renal Cell Carcinoma.医学治疗对晚期肾细胞癌骨代谢的影响
Cancers (Basel). 2023 Jan 15;15(2):529. doi: 10.3390/cancers15020529.
3
Tyrosine Kinase Inhibitors Regulate OPG through Inhibition of PDGFRβ.
酪氨酸激酶抑制剂通过抑制血小板衍生生长因子受体β（PDGFRβ）来调节骨保护素（OPG）。
PLoS One. 2016 Oct 13;11(10):e0164727. doi: 10.1371/journal.pone.0164727. eCollection 2016.
4
Effects of imatinib and nilotinib on the whole transcriptome of cultured murine osteoblasts.伊马替尼和尼罗替尼对培养的小鼠成骨细胞全转录组的影响。
Mol Med Rep. 2016 Sep;14(3):2025-37. doi: 10.3892/mmr.2016.5459. Epub 2016 Jun 30.
5
Impact of long-term exposure to the tyrosine kinase inhibitor imatinib on the skeleton of growing rats.长期暴露于酪氨酸激酶抑制剂伊马替尼对生长中大鼠骨骼的影响。
PLoS One. 2015 Jun 24;10(6):e0131192. doi: 10.1371/journal.pone.0131192. eCollection 2015.
6
Use of imatinib in the prevention of heterotopic ossification.使用伊马替尼预防异位骨化。
HSS J. 2013 Jul;9(2):166-70. doi: 10.1007/s11420-013-9335-y. Epub 2013 Jun 21.
7
Clinical review: kinase inhibitors: adverse effects related to the endocrine system.临床综述：激酶抑制剂：与内分泌系统相关的不良反应。
J Clin Endocrinol Metab. 2013 Apr;98(4):1333-42. doi: 10.1210/jc.2012-4085. Epub 2013 Feb 28.
8
SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation.SPARC 在 CML 中的表达与伊马替尼治疗和白血病细胞增殖抑制有关。
BMC Cancer. 2013 Feb 5;13:60. doi: 10.1186/1471-2407-13-60.
9
Changes in bone metabolic parameters in children with chronic myeloid leukemia on imatinib treatment.伊马替尼治疗慢性髓性白血病儿童的骨代谢参数变化。
Med Sci Monit. 2012 Dec;18(12):CR721-8. doi: 10.12659/msm.883599.
10
Bone metabolism, growth rate and pubertal development in children with chronic myeloid leukemia treated with imatinib during puberty.青春期接受伊马替尼治疗的慢性髓性白血病儿童的骨代谢、生长速率及青春期发育
Haematologica. 2013 Mar;98(3):e25-7. doi: 10.3324/haematol.2012.067447. Epub 2012 Sep 14.